Company / Working Capital
Erasca, Inc. Working Capital History
FY2020-FY2024 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Working Capital
$277.4M
FY2024
5-year range
$106.3M / $395.8M
FY2020-FY2024
Trend
-5.8%
vs FY2023
Sector context
#151 of 213
Health Care
What the data says
At $277M, Erasca, Inc.'s working capital ranks #151 of 213 in the Health Care sector. Declined from $396M to $277M over the past 2 years.
Based on SEC 10-K filings.
$277M in FY2024 with a 3-year CAGR of -11.0%.
Declined from $396M to $277M over the past 2 years.
Health Care sector context is included.
Working Capital over time
Growth rates
- 3-Year CAGR
- -11.0%
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Sector benchmark
#151 of 213 in Health CareTop 71% of 213This company $277.4M Sector average $934.6M
▼
-70.3% below sector average
Key checks
Key Insights
- 3-year CAGR of -11.0%, indicating a declining trend.
- In FY2024, working capital decreased 5.8% year-over-year.
- Ranks #151 out of 213 companies in the Health Care sector.
- Peak working capital was recorded in FY2022.
Company context
Key Data Points
- Low Piotroski F-Score: 1/9 (multiple financial health concerns)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Working CapitalValue | YoY GrowthYoY |
|---|---|---|
| FY2024 | $277.4M | -5.8% |
| FY2023 | $294.5M | -25.6% |
| FY2022 | $395.8M | +0.5% |
| FY2021 | $393.8M | +270.4% |
| FY2020 | $106.3M | - |
As of FY2024 · SEC 10-K · Updated Feb 28, 2026